Indication

hepatic arterial infusion chemotherapy

2 clinical trials

2 products

2 drugs

Clinical trial

Hepatic Arterial Infusion Chemotherapy Combined Sintilimab for Predominant Liver Metastasis From Esophageal Squamous Cell Carcinoma- A Pilot Study

Status: Completed, Estimated PCD: 2023-10-18

Product

HAIC combined with intravenous PD-1

Clinical trial

Efficacy of HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma: an Observational, Real-world Study

Status: Recruiting, Estimated PCD: 2024-12-30

Product

Drug

PD-1 monoclonal antibody

Drug